- Product
- Paxlovid transition to general health system effective June
- by Apr 11, 2025 06:01am
- Paxlovid, a treatment for COVID-19, will be transitioned to the general healthcare system starting in June. The free supply previously provided to centers designated for COVID-19 treatment (prescribing facilities) will be terminated entirely due to stock depletion. According to local pharmacists, on the 9th, various local public health
- Product
- Distributors of Neurontin, Lyrica, and Celebrex to change
- by Kim JiEun Feb 14, 2025 05:58am
- With the transfer of sales rights between domestic pharmaceutical companies for major original products expected, the change is expected to affect not only the pharmaceutical and distribution industries but also front-line pharmacies. According to the pharmaceutical wholesale industry sources on the 13th, the transfer of rights to domes
- Product
- Non-face-to-face treatment takes another hit
- by Jung, Heung-Jun Feb 12, 2025 06:13am
- Following the restriction of Wegovy prescriptions through non-face-to-face medical care, voices are rising on the need to regulate the prescription of artificial tears as well. The platform industry believes that overprescription is an issue that occurs regardless of whether the patient receives face-to-face or non-face-to-face care. The
- Product
- Wegovy outpatient prescriptions ↓…pharmacy burden↑
- by Jung, Heung-Jun Feb 12, 2025 06:13am
- Wegovy, whose sales suffered due to inventory shortage in pharmacies, has now become an intractable inventory four months after its launch in Korea. Wegovy is a self-injectable drug that requires refrigeration and is a non-returnable product. Each unit costs tens of thousands of won, so pharmacies bear a heavy burden if it becomes a dead
- Product
- Will doctor-pharmacist conflict reignite?
- by Kim JiEun Jan 7, 2025 06:05am
- With candidate Joo Soo-ho, who advocates for the selective dispensing of drugs, advancing to the runoff election for the new president of the Korean Medical Association, a potential conflict between the medical community and the pharmaceutical association is expected. In the 43rd presidential election of the Korean Medical Association, wh
- Product
- Price of Pulmican, Pulmicort, Tantum Sol to be raised in Jan
- by Kang Hye-Kyung Dec 27, 2024 05:56am
- As of January 1 next year, items including Pulmican, Pulmicort, and Tantum Sol which are set to receive price hikes, will demand the pharmacists' attention. According to a notice from the Ministry of Health and Welfare on the 24th, the price of ▲ Whanin Imipramine HCl Tab 25mg ▲ Lithan Tab ▲ Myungin Lithium Carbonate Tab ▲ Myungin Lithium
- Product
- Gout drug allopurinol side effect alert
- by Kang, Shin-Kook Nov 20, 2024 06:08am
- As reports of adverse reactions to allopurinol, a drug prescribed for gout, continue to mount, health authorities are calling for genetic testing of patients before prescribing it to prevent side effects. According to medical and pharmaceutical associations on the 19th, the NMC Adverse Drug Reaction&160;Committee recently reviewed applicatio
- Product
- MOHW cautions non-face-to-face Wegovy prescriptions
- by Kang Hye-Kyung Nov 13, 2024 05:55am
- The government has asked medical institutions for cooperation in making indiscriminate Wegovy prescriptions. The Ministry of Health and Welfare said on the 11th through the medical community, “Regarding Wegovy, which was recently released as a treatment for obesity, medical institutions are issuing prescriptions without sufficiently e
- Product
- KTIC, ’21s Wegovy prescriptions, not a telemedicine issue'
- by Kang, Hye-Kyung Nov 7, 2024 05:47am
- the platform industry has spoken out to state its opinion regarding the government’s move to restrict non-face-to-face prescriptions in response to the criticism that 'obesity drugs are being easily prescribed &8211; just in 21 seconds - through non-face-to-face medical treatment platforms.’ While the platform industry sympathizes with
- Product
- KMA ‘non-face-to-face Wegovy prescriptions cause harm'
- by Kang, Shin-Kook Oct 30, 2024 05:53am
- A Korean doctor's association has called for an immediate halt to the government's plan to allow non-face-to-face medical treatment. The Korean Medical Association (Chairman Hyun-Taek Lim) issued a statement on the 28th claiming, “The government should immediately stop allowing all non-face-to-face medical treatment as its pilot project
